Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Focusing on CD8+ T-cell phenotypes: improving solid tumor therapy
Z Yao, Y Zeng, C Liu, H **, H Wang, Y Zhang… - Journal of Experimental …, 2024 - Springer
Vigorous CD8+ T cells play a crucial role in recognizing tumor cells and combating solid
tumors. How T cells efficiently recognize and target tumor antigens, and how they maintain …
tumors. How T cells efficiently recognize and target tumor antigens, and how they maintain …
[HTML][HTML] Strategies for improving CAR T Cell persistence in solid tumors
Simple Summary CAR T cell therapies have been successful at treating patients with blood
cancers and are now FDA-approved therapies for various types of leukemias and …
cancers and are now FDA-approved therapies for various types of leukemias and …
Unlocking Apoptotic Pathways: Overcoming Tumor Resistance in CAR‐T‐Cell Therapy
Z Zhang, M Su, P Jiang, X Wang, X Tong… - Cancer …, 2024 - Wiley Online Library
Background Chimeric antigen receptor (CAR)‐T‐cell therapy has transformed cancer
treatment, leading to remarkable clinical outcomes. However, resistance continues to be a …
treatment, leading to remarkable clinical outcomes. However, resistance continues to be a …
Improving the efficacy of cancer immunotherapy by host-defence caerin 1.1 and 1.9 peptides
Q Fu, Y Luo, J Li, P Zhang, S Tang, X Song… - Human Vaccines & …, 2024 - Taylor & Francis
Cancer remains a major global health challenge. Immunotherapy has revolutionized the
management of cancer, yet only a limited number of patients respond to such treatments …
management of cancer, yet only a limited number of patients respond to such treatments …
Optimising CAR T therapy for the treatment of solid tumors
Introduction Adoptive immunotherapy using chimeric antigen receptor (CAR)-engineered T
cells has proven transformative in the management of B cell and plasma cel derived …
cells has proven transformative in the management of B cell and plasma cel derived …
BH3 Mimetics Augment Cytotoxic T Cell Killing of Acute Myeloid Leukemia via Mitochondrial Apoptotic Mechanism
Adoptive cell therapy (ACT) can address an unmet clinical need for patients with
relapsed/refractory acute myeloid leukemia (AML), but its effect is often modest in the setting …
relapsed/refractory acute myeloid leukemia (AML), but its effect is often modest in the setting …